OICR-9429 significantly reduced BC cell line migration in a dose-dependent manner (Fig. 6a and Additional file 1: S7A), while it did not affect the migration of the MCF10A non-transformed cells (Additional file 1: Figure S7B), suggesting that WDR5 inhibition may exert specific effects on tumor cells. The gene discussed is WDR5; the disease is breast cancer.